New vitamin B12 therapy shows promise against deadly brain cancer

Scientists have discovered a vitamin B12-based compound that may offer hope for glioblastoma patients, a particularly aggressive form of brain cancer. This new therapy can penetrate the blood-brain barrier and target tumors specifically, delivering nitric oxide directly to cancer cells and boosting the effectiveness of current treatments. The potential of this breakthrough lies in its ability to combine with existing therapies to provide a more powerful attack on glioblastoma, marking a significant step forward in cancer treatment research.